Détention brevets de la classe C07C 233/56

Brevets de cette classe: 119

Historique des publications depuis 10 ans

12
12
8
4
9
6
4
9
3
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
Theravance Biopharma R&D IP, LLC
458
16
University of Mississippi
156
6
The General Hospital Corporation
4735
5
The Broad Institute, Inc.
1822
5
Massachusetts Institute of Technology
10057
4
Agro-kanesho Co., Ltd.
48
4
The Board of Regents of the University of Texas System
2207
4
The Trustees of Columbia University in the City of New York
3577
3
Carmel-Haifa University Economic Corporation Ltd.
81
3
Max-delbruck-centrum fur Molekulare Medizin
50
3
MedImmune Limited
616
3
Omeicos Therapeutics GmbH
7
3
PI Industries Ltd
161
3
Bristol-myers Squibb Company
4884
2
Syngenta Crop Protection AG
6067
2
FUJIFILM Corporation
29424
2
Board of Regents, The University of Texas System
5798
2
MCW Research Foundation, Inc.
23
2
The Medical College of Wisconsin, Inc.
402
2
Merial, Inc.
220
2
Autres propriétaires 43